SG Americas Securities’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$96.1M Buy
435,283
+135,928
+45% +$37.6M 0.05% 215
2026
Q1
$88.4M Buy
299,355
+61,457
+26% +$18.3M 0.1% 169
2025
Q4
$65M Buy
237,898
+184,459
+345% +$50.1M 0.08% 183
2025
Q3
$14.4M Sell
53,439
-132,903
-71% -$36.2M 0.05% 253
2025
Q2
$51.4M Buy
186,342
+133,694
+254% +$36.4M 0.21% 66
2025
Q1
$14M Sell
52,648
-238,912
-82% -$58.9M 0.05% 254
2024
Q4
$67.7M Buy
291,560
+284,353
+3,946% +$65.4M 0.28% 42
2024
Q3
$1.59M Sell
7,207
-127,467
-95% -$26.4M 0.01% 783
2024
Q2
$26.5M Buy
134,674
+77,906
+137% +$16.1M 0.15% 128
2024
Q1
$12.2M Buy
56,768
+42,996
+312% +$9.03M 0.06% 313
2023
Q4
$2.9M Buy
13,772
+4,235
+44% +$904K 0.03% 518
2023
Q3
$1.91M Sell
9,537
-26,769
-74% -$5.32M 0.02% 765
2023
Q2
$6.73M Buy
36,306
+27,786
+326% +$5.13M 0.05% 279
2023
Q1
$1.63M Buy
8,520
+4,707
+123% +$851K 0.02% 799
2022
Q4
$641K Sell
3,813
-18,198
-83% -$3.16M 0.01% 1322
2022
Q3
$3.9M Buy
22,011
+13,416
+156% +$2.65M 0.05% 315
2022
Q2
$1.76M Sell
8,595
-10,079
-54% -$2.14M 0.02% 815
2022
Q1
$4.44M Sell
18,674
-2,012
-10% -$473K 0.03% 472
2021
Q4
$4.73M Sell
20,686
-1,843
-8% -$406K 0.03% 531
2021
Q3
$4.36M Sell
22,529
-16,924
-43% -$3.43M 0.02% 634
2021
Q2
$8.39M Buy
39,453
+4,234
+12% +$894K 0.04% 413
2021
Q1
$7.19M Buy
35,219
+1,366
+4% +$269K 0.04% 387
2020
Q4
$6.16M Buy
33,853
+30,456
+897% +$5.18M 0.03% 407
2020
Q3
$568K Sell
3,397
-36,911
-92% -$6.22M ﹤0.01% 1548
2020
Q2
$6.55M Buy
40,308
+22,634
+128% +$4.06M 0.05% 262
2020
Q1
$3.06M Buy
17,674
+10,523
+147% +$2.09M 0.03% 586
2019
Q4
$1.44M Sell
7,151
-42,643
-86% -$8.75M 0.01% 1040
2019
Q3
$10.5M Sell
49,794
-2,696
-5% -$563K 0.09% 234
2019
Q2
$10.2M Sell
52,490
-8,530
-14% -$1.57M 0.07% 269
2019
Q1
$10M Sell
61,020
-73,311
-55% -$13M 0.09% 222
2018
Q4
$25.3M Buy
134,331
+86,741
+182% +$16M 0.22% 92
2018
Q3
$8.1M Sell
47,590
-15,154
-24% -$2.55M 0.06% 328
2018
Q2
$10.3M Buy
62,744
+25,901
+70% +$4.23M 0.09% 213
2018
Q1
$5.96M Sell
36,843
-69,699
-65% -$11.1M 0.05% 349
2017
Q4
$15.6M Buy
106,542
+59,481
+126% +$8.47M 0.15% 115
2017
Q3
$6.38M Buy
47,061
+18,916
+67% +$2.39M 0.06% 254
2017
Q2
$3.52M Sell
28,145
-47,073
-63% -$5.63M 0.03% 534
2017
Q1
$8.94M Sell
75,218
-2,278
-3% -$274K 0.08% 226
2016
Q4
$8.94M Buy
77,496
+60,953
+368% +$6.78M 0.08% 263
2016
Q3
$1.73M Buy
16,543
+13,936
+535% +$1.45M 0.02% 824
2016
Q2
$254K Sell
2,607
-14,815
-85% -$1.4M ﹤0.01% 2001
2016
Q1
$1.67M Buy
17,422
+6,611
+61% +$601K 0.01% 974
2015
Q4
$979K Sell
10,811
-6,915
-39% -$651K 0.01% 1155
2015
Q3
$1.64M Buy
17,726
+15,590
+730% +$1.48M 0.01% 681
2015
Q2
$199K Sell
2,136
-22,206
-91% -$2.07M ﹤0.01% 1991
2015
Q1
$2.31M Sell
24,342
-107,124
-81% -$9.92M 0.01% 749
2014
Q4
$11.7M Buy
131,466
+97,290
+285% +$8.24M 0.06% 339
2014
Q3
$2.73M Sell
34,176
-44,172
-56% -$3.33M 0.02% 750
2014
Q2
$5.56M Sell
78,348
-89,483
-53% -$6.3M 0.03% 543
2014
Q1
$12.4M Buy
167,831
+79,761
+91% +$6.02M 0.05% 378
2013
Q4
$6.91M Sell
88,070
-35,457
-29% -$2.78M 0.03% 538
2013
Q3
$9.13M Buy
123,527
+11,955
+11% +$881K 0.04% 438
2013
Q2
$8.48M Buy
+111,572
New +$7.32M 0.04% 416

Other funds holding CME

SG Americas Securities's CME Position: Q2 2026 in Review

SG Americas Securities increased its CME Group (CME) stake by 45% in Q2 2026, buying an estimated $37.6M and bringing the position to 435,283 shares worth $96.1M. The position accounts for 0.05% of the portfolio, ranked #215.

SG Americas Securities first reported a position in CME in Q2 2013 and has held it in 53 quarters since. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • SG Americas Securities held 435,283 shares of CME Group worth $96.1M as of Q2 2026.
  • SG Americas Securities bought 135,928 CME Group shares in Q2 2026, an estimated $37.6M.
  • CME Group made up 0.05% of SG Americas Securities's portfolio in Q2 2026, its #215 holding.
  • SG Americas Securities first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.